U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07365709) titled 'Liver Cirrhosis Complicated by Clinically Significant Portal Hypertension' on Jan. 16.
Brief Summary: Portal hypertension is a major complication of cirrhosis. HVPG is the diagnostic gold standard but is invasive. Non-invasive tools such as spleen stiffness measurement (SSM) and CEUS show promise for assessing CSPH, though they have not yet been compared directly. A multimodal ultrasound approach may provide a reliable alternative to HVPG.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Portal Hypertension
Spleen Disease
Cirrhosis
Intervention:
DRUG: SonoVue
microbubbles infusion and ultrasound
Recruitment St...